The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1496
June 6, 2016
View Complete Issue         Table of Contents 2019 
Alternatives to Fluoroquinolones
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Alternatives to Fluoroquinolones
June 6, 2016 (Issue: 1496)
The FDA has announced that it is requiring changes in the labeling of systemic fluoroquinolones to warn that the risk of serious adverse effects, including tendinitis, peripheral neuropathy and CNS effects, generally outweighs their benefit for...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Alternatives to Fluoroquinolones
Article code: 1496c
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.